ClinicalTrials.gg
RecruitingNCT02811900ChirBarUpdated Nov 9, 2017

An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study

An observational study in Morbid Obesity, sponsored by IHU Strasbourg. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-09.

Sponsored by IHU Strasbourg · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Obesity, Morbid by IHU Strasbourg — 3 open to participants now, 3 under way, none of them phase 3. Obesity, Morbid · IHU Strasbourg.

Started
1996
the only one that year
Observational
3 of 10
2 open now
Registered
4th of 10
by date

Among the 10 studies in Obesity, Morbid by IHU Strasbourg, this one is the only one that started in 1996, is one of 3 observational ones, and was the 4th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

3 of the 10 studies in Obesity, Morbid by IHU Strasbourg are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Obesity, Morbid by IHU Strasbourg, or all of them as a file.
02

Study summary

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group).

Read the detailed description

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization. Patients were evaluated by a multidisciplinary team. The standard preoperative assessment included nutritional counseling, psychological evaluation, abdominal ultrasound, upper gastrointestinal endoscopy, and blood tests. Type and date of surgery, biological and clinical follow-up data and morbidity data were recorded prospectively in the database.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group). Patients who had IH were paired with patients of the same age and sex and at the same postoperative interval. Paired patients were contacted by phone to obtain the QoL questionnaires, abdominal pain evaluation, and weight loss data.

03

Conditions studied

  • Morbid Obesity

Browse trials for

Keywords

  • obesity surgery
  • Roux en Y gastric bypass
  • sleeve gastrectomy
  • excess weight loss
  • quality of life
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient >18 years old BMI >35 kg/m²

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient >18 years old
  • > 35 kg/m²

Exclusion criteria

Exclusion Criteria:

  • Incapacity of giving an
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Target follow-up
30 Years
Patient registry
Yes

Interventions

  • ProcedureRoux en Y gastric bypass

    Laparoscopic RYGB is performed as following: a gastric pouch of approximately 30mL was obtained using successive firings of the Endo GIATM linear stapler, followed by the creation of an antecolic alimentary limb of 150cm and of a biliopancreatic limb of 75cm. A gastrojejunal anastomosis was fashioned with the PCEEA™ 28 circular stapler until 2012, and using the Endo GIA™ linear stapler afterwards. The mesenteric defect and Petersen's defect were closed using a non-absorbable running suture.

  • ProcedureSleeve gastrectomy

    Laparoscopic SG is performed as following: after greater curvature mobilization, the gastric tube was calibrated over a 36F bougie and transection started approximately 5-6 cm from the pylorus toward the left diaphragmatic crus, using successive firings of 3.5- or 4.8-mm-high staples, depending on gastric thickness.

  • ProcedureGastric banding

    Laparoscopic gastric banding is performed as following: a perigastric tunel is performed by blunt dissection and the banding is calibrated over the stomach.

  • ProcedureIntragastric balloon

    Flexible endoscopy is used to place intragastric balloon for a maximum interval of six months.

06

What researchers measure

Primary outcomes

  1. Excess weight loss

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

Secondary outcomes

  1. BMI

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  2. Albumin

    Albumin

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  3. Pre-albumin

    Pre-albumin

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  4. Vitamin A

    Vitamin A

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  5. Vitamin D

    Vitamin D

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  6. Vitamin B6

    Vitamin B6

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  7. Vitamin B9

    Vitamin B9

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  8. Vitamin B12

    Vitamin B12

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  9. Plasma ferritin

    Plasma ferritin

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  10. Fasting plasma glucose

    Fasting plasma glucose

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  11. Serum insulin

    Serum insulin

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  12. HbA1c

    HbA1c

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  13. Triglycerides

    Triglycerides

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  14. Cholesterol

    Cholesterol (total, HDL, LDL)

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  15. Quality of life assessed by Moorehead-Ardelt Quality of life II questionnaire

    Moorehead-Ardelt Quality of life II questionnaire

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  16. Quality of life assessed by Gastro-intestinal Quality of Life Index

    Gastro-intestinal Quality of Life Index

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

  17. Postoperative morbidity

    Postoperative morbidity

    Time frame: 1 - 3 - 5 - 10 - 15 and 30 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Lunca S, Vix M, Rikkers A, Rubino F, Marescaux J. Late gastric prolapse with pouch necrosis after laparoscopic adjustable gastric banding. Obes Surg. 2005 Apr;15(4):571-5. doi: 10.1381/0960892053723420. PubMed 15946441 ↗
  • Donatelli G, Costantino F, Dhumane P, Vix M, Perretta S, D' Agostino J, Dallemagne B, Marescaux J. Endoscopic intragastric balloon: a bridge toward definitive bariatric surgical management of a morbidly obese patient with situs ambiguous and midgut malrotation (with videos). Gastrointest Endosc. 2012 Jan;75(1):217-8. doi: 10.1016/j.gie.2011.01.022. Epub 2011 Mar 27. No abstract available. PubMed 21444079 ↗
  • Vix M, Diana M, Liu KH, D'Urso A, Mutter D, Wu HS, Marescaux J. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg. 2013 May;23(5):613-21. doi: 10.1007/s11695-012-0827-5. PubMed 23207829 ↗
  • Vix M, Liu KH, Diana M, D'Urso A, Mutter D, Marescaux J. Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial. Surg Endosc. 2014 Mar;28(3):821-6. doi: 10.1007/s00464-013-3276-x. Epub 2013 Nov 7. PubMed 24196556 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 1996, a primary completion of Dec 2026 and a completion of Dec 2026. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2016
First posted
Jun 23, 2016
Start
Jan 1996
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Nov 9, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 9, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02811900
Lead sponsor
IHU Strasbourg
Responsible party
Sponsor
First posted
Jun 23, 2016
Start date
Jan 1996
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 9, 2017

Study contacts

Didier Mutter, MD, PhD
Contact
didier.mutter@chru-strasbourg.fr
+33 (0)3 90 11 90 41
Didier Mutter, MD, PhD
study chair · Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion